Get started
Author

Diana A. van Riet‐Nales

Observed names: D A Van Riet-Nales, D A van Riet-Nales, D Van Riet-Nales, D. A. van Riet-Nales, D. v. Riet-Nales, D.A van Riet-Nales, D.A. Nales, D.A. van Riet-Nales, DA van Riet-Nales, Diana A Van Riet-nales, Diana A van Riet-Nales, Diana A. Van Riet-Nales, Diana A. van Riet Nales, Diana A. van Riet – Nales, Diana A. van Riet-Nales, Diana Van Riet-Nales, Diana van Riet, Diana van Riet-Nales, Diana van Riet‐Nales, Diana van Riet–Nales, Nales, D.A., Riet-Nales, Diana A., Van Riet-Nales, D. A., Van Riet-Nales, Diana, Van Riet-Nales, Diana A., van Riet-Nales, D, van Riet-Nales, DA
ORCID: 0000-0002-4902-4519
Observed ORCID: 0000-0002-4902-4519
OpenAlex ID: A5087254353
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
2019 · Mirko Koziolek, Stefano Alcaro, et al. · European Journal of Pharmaceutical Sciences · 385
PDF
Acceptability of different oral formulations in infants and preschool children
2013 · D. A. van Riet-Nales, B. J. de Neef, et al. · Archives of Disease in Childhood · 136
Practical Problems with Medication Use that Older People Experience: A Qualitative Study
2014 · Kim Notenboom, Erna Beers, et al. · Journal of the American Geriatrics Society · 112
PDF
Defining Patient Centric Pharmaceutical Drug Product Design
2016 · Sven Stegemann, Robert L. Ternik, et al. · The AAPS Journal · 102
PDF
The accuracy, precision and sustainability of different techniques for tablet subdivision: Breaking by hand and the use of tablet splitters or a kitchen knife
2014 · Diana A. van Riet-Nales, Myrthe E. Doeve, et al. · International Journal of Pharmaceutics · 98
PDF
Paediatric Drug Development and Formulation Design—a European Perspective
2016 · Diana A. Van Riet-Nales, Piotr Kozarewicz, et al. · AAPS PharmSciTech · 87
PDF
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
2016 · Diana A van Riet-Nales, Alfred F A M Schobben, et al. · Archives of Disease in Childhood · 87
PDF
Methods of administering oral formulations and child acceptability
2015 · Diana A. van Riet-Nales, José A. Ferreira, et al. · International Journal of Pharmaceutics · 69
PDF
Patients’ appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence
2017 · Nélio Drumond, Diana A. van Riet-Nales, et al. · International Journal of Pharmaceutics · 66
The availability and age‐appropriateness of medicines authorized for children in the Netherlands
2011 · Diana A. van Riet‐Nales, Karin E. de Jager, et al. · British Journal of Clinical Pharmacology · 58
PDF
Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: A systematic literature review
2010 · Diana A. van Riet-Nales, Alfred F.A.M. Schobben, et al. · Clinical Therapeutics · 39
The EMA quality guideline on the pharmaceutical development of medicines for paediatric use
2012 · Diana A. van Riet-Nales, Siri Wang, et al. · International Journal of Pharmaceutics · 29
Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects
2016 · Diana A. van Riet-Nales, Nasir Hussain, et al. · International Journal of Pharmaceutics · 28
PDF
Results from a preliminary review of scientific evidence for appropriateness of preparations, dosage forms and other product design elements for older adult patients
2014 · Rossella Messina, Robert Becker, et al. · International Journal of Pharmaceutics · 24
Oral Medicines for Children in the European Paediatric Investigation Plans
2014 · Diana A. van Riet – Nales, Erwin G. A. W. Römkens, et al. · PLoS ONE · 23
PDF
Association between culture and the preference for, and perceptions of, 11 routes of medicine administration: A survey in 21 countries and regions
2023 · Sudaxshina Murdan, Li Wei, et al. · Exploratory Research in Clinical and Social Pharmacy · 17
European Paediatric Formulation Initiative workshop report: Improving the administration of oral liquid medicines in paediatrics using dosing syringes and enteral accessories
2020 · Jennifer Walsh, Diana van Riet-Nales, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 13
PDF
Age-Related Medicine
2019 · John Wahlich, Mine Orlu, et al. · Pharmaceutics · 12
PDF
Opportunities for changes in the drug product design to enhance medication safety in older people: Evaluation of a national public portal for medication incidents
2020 · Fatma Karapinar‐Çarkit, Patricia M.L.A. van den Bemt, et al. · British Journal of Clinical Pharmacology · 11
PDF
The development of a test battery to assess the hand–eye functions relevant in predicting easy and accurate tablet subdivision in older people: A pilot study
2019 · Diana van Riet–Nales, Linda Donkerbroek, et al. · British Journal of Clinical Pharmacology · 11
PDF
Achieving appropriate medication for older adults: A multidimensional perspective
2019 · Luis Mieiro, Jean-Baptiste Beuscart, et al. · Maturitas · 11
PDF
Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
2020 · Sven Stegemann, Diana van Riet‐Nales, et al. · British Journal of Clinical Pharmacology · 10
PDF
Actual versus recommended storage temperatures of oral anticancer medicines at patients’ homes
2017 · ND Vlieland, BJF van den Bemt, et al. · Journal of Oncology Pharmacy Practice · 9
PDF
Developing patient‐centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population
2020 · Diana A. van Riet‐Nales, Katarina Sundberg, et al. · British Journal of Clinical Pharmacology · 8
PDF
An improved in vitro method for the evaluation of antacids with in vivo relevance
2002 · D.A van Riet-Nales, P van Aalst, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 7
Works count: 59
Citation count: 1,468
H-index: 16
I10-index: 21
Year
Topic
Type